There are no articles that matched your search criteria.
Designing radiopharmaceuticals involves combining the right radioisotope with a targeting molecule, in order to take it to the tumor. The selection of the targeting molecule depends upon the type of cancer. In the case of breast cancer, for example, a hormone molecule might be used.
Henry is also involved in a number of research projects outside of the COTC, focusing on spontaneously occurring cancer in animals, more specifically breast cancer, bone cancer, and bladder cancer. Chuckling, she remarks, “so I guess any tumor that starts with a ‘b’ is what I’m focused on right now.”